Growth Metrics

Re (RMAX) EBIAT (2016 - 2025)

Re (RMAX) has disclosed EBIAT for 14 consecutive years, with $6.7 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIAT rose 2.94% to $6.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.4 million, a 66.31% increase, with the full-year FY2025 number at $13.4 million, up 66.31% from a year prior.
  • EBIAT was $6.7 million for Q4 2025 at Re, up from $3.3 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $11.1 million in Q4 2023 to a low of -$82.7 million in Q3 2023.
  • A 5-year average of -$3.1 million and a median of $2.4 million in 2021 define the central range for EBIAT.
  • Biggest YoY gain for EBIAT was 599.32% in 2023; the steepest drop was 7796.08% in 2023.
  • Re's EBIAT stood at -$11.6 million in 2021, then soared by 80.85% to -$2.2 million in 2022, then soared by 599.32% to $11.1 million in 2023, then crashed by 41.11% to $6.5 million in 2024, then increased by 2.94% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for RMAX's EBIAT are $6.7 million (Q4 2025), $3.3 million (Q3 2025), and $6.7 million (Q2 2025).